Atrix to call remaining convertibles

New York, March 26 - Atrix Laboratories, Inc. said it will call its remaining 7% convertible subordinated notes due 2004.

The Fort Collins, Colo. specialty pharmaceutical company said it will redeem the notes on May 15 at a price of 102.25 plus accrued interest.

The notes can be converted ahead of the redemption at $19 per share. Atrix stock closed at $22.32 on Monday.

Atrix said it has $2.875 million of the convertibles still outstanding from the $50 million public offering in November 1997.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.